Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
8245157
Reference Type
Journal Article
Title
Involvement of P2 receptors in hematopoiesis and hematopoietic disorders, and as pharmacological targets
Author(s)
Filippin, KJ; De Souza, KFS; De Araujo Jãºnior, RT; Torquato, HFV; Dias, DA; Parisotto, EB; Ferreira, AT; Paredes-Gamero, EJ
Year
2020
Is Peer Reviewed?
1
Journal
Purinergic Signalling
ISSN:
1573-9538
EISSN:
1573-9546
Publisher
Springer
Volume
16
Issue
1
Language
English
DOI
10.1007/s11302-019-09684-z
Abstract
Several reports have shown the presence of P2 receptors in hematopoietic stem cells (HSCs). These receptors are activated by extracellular nucleotides released from different sources. In the hematopoietic niche, the release of purines and pyrimidines in the milieu by lytic and nonlytic mechanisms has been described. The expression of P2 receptors from HSCs until maturity is still intriguing scientists. Several reports have shown the participation of P2 receptors in events associated with modulation of the immune system, but their participation in other physiological processes is under investigation. The presence of P2 receptors in HSCs and their ability to modulate this population have awakened interest in exploring the involvement of P2 receptors in hematopoiesis and their participation in hematopoietic disorders. Among the P2 receptors, the receptor P2X7 is of particular interest, because of its different roles in hematopoietic cells (e.g., infection, inflammation, cell death and survival, leukemias and lymphomas), making the P2X7 receptor a promising pharmacological target. Additionally, the role of P2Y12 receptor in platelet activation has been well-documented and is the main example of the importance of the pharmacological modulation of P2 receptor activity. In this review, we focus on the role of P2 receptors in the hematopoietic system, addressing these receptors as potential pharmacological targets. © 2019, Springer Nature B.V.
Keywords
Hematopoiesis; Hematopoietic stem cell; Leukemia; P2 receptor; Pharmacological target; Platelets
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity